VACCINES universal generation, which is part of new drugs by using the body's own immune system to fight diseases such as tumors will be available within two years.
A vaccine called TeloVac is sometimes a revolutionary cancer treatment. Hopefully, this vaccine will be effective against various types of tumors, including lung, skin, liver, breast, and prostate cancer.
Instead of attacking cancer cells, such as regular drugs, vaccines harness the power of the immune system to fight tumors.
This vaccine works by stimulating the immune system to seek out and destroy an enzyme called telomerase. This enzyme is often found in cases of cancer cell tingggi level and could make the cancer cells survive, even when healthy cells to die. This resulted in the spread of tumors.
If a recent study funded by Cancer Research UK is proven feasible, this vaccine could be available to treat advanced pancreatic cancer in late 2013. In time, it can be used at the beginning of the disease - and even to prevent it.
A vaccine called TeloVac is sometimes a revolutionary cancer treatment. Hopefully, this vaccine will be effective against various types of tumors, including lung, skin, liver, breast, and prostate cancer.
Instead of attacking cancer cells, such as regular drugs, vaccines harness the power of the immune system to fight tumors.
This vaccine works by stimulating the immune system to seek out and destroy an enzyme called telomerase. This enzyme is often found in cases of cancer cell tingggi level and could make the cancer cells survive, even when healthy cells to die. This resulted in the spread of tumors.
If a recent study funded by Cancer Research UK is proven feasible, this vaccine could be available to treat advanced pancreatic cancer in late 2013. In time, it can be used at the beginning of the disease - and even to prevent it.
"We strongly believe this vaccine has the potential to overcome the limits of other cancer vaccines in use today and become part of the standard of care not only for pancreatic cancer, but also for various types of cancer," said Sangjae Dr. Jay Kim, founder of GemVax, Korean firms TeloVac who developed the vaccine, as quoted by the Daily Mail.
"In other words, the vaccine is truly 'universal' will be available in the near future," added Kim.
Read: Pills to Prevent Development of Tumor
